CompletedNot Applicable

Metabolic Syndrome in Childhood Cancer Survivors

United States512 participantsStarted 2005-04

Plain-language summary

RATIONALE: Gathering information about how often metabolic syndrome occurs in young survivors of childhood cancer may help doctors learn more about the disease. PURPOSE: This clinical trial is studying metabolic syndrome in survivors of childhood cancer and in their healthy sisters and brothers.

Who can participate

Age range9 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects must be survivors of childhood cancer, treated at Fairview-University Medical Center or Children's Hospitals and Clinics of Minneapolis and St Paul or siblings of survivors. * Subjects will be 9-17 years old at the time of their visit. * Subjects who are cancer survivors must have survived childhood cancer for a minimum of 5 years and be in remission. Exclusion Criteria: * Eligibility will not be restricted by race or sex. * Any women currently pregnant will not be eligible, but may participate 3 or more months after the end of her pregnancy if the study is still ongoing. * Subjects who underwent hematopoietic cell transplant (HCT) are not eligible for this study.

What they're measuring

Metabolic syndrome (MS) in survivors of childhood cancer (CCS) vs controls

Timeframe: Day 1 and Day 2

Insulin resistance (IR) in CCS vs controls

Timeframe: Day 1 and Day 2

Correlation of obesity and IR to other factors associated with the development of the MS that may be altered in the CCS

Timeframe: Day 1 and Day 2

Dietary and a physical activity assessments of CCS vs controls

Timeframe: Day 1 and Day 2

Trial details

NCT IDNCT00920738

SponsorUniversity of Minnesota

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-07

View on ClinicalTrials.gov More Brain and Central Nervous System Tumors trials